Exicure, Inc. (“Exicure” or the “Company”) (Nasdaq: XCUR) a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced that, as of July 1, 2025, the Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback